For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 (IgG3) stops the immune system's B cells from doing their normal job of ...

Active host-pathogen interactions take place during infection of human immunodeficiency virus type 1 (HIV-1). Outcomes of these interactions determine the efficiency of viral infection and subsequent ...

The human immunodeficiency virus (HIV)-1 we are currently struggling to contain is the result of a long chain of viral cross-species transmission events in African non-human primates. Many species of ...

Researchers at Duke Human Vaccine Institute (DHVI) have identified a new type of anti-glycan antibody (Ab) that binds to a patch of the chain-like sugars on the outer shell of HIV, effectively ...

Researchers have found a new way to deliver an HIV vaccine that enhances the body's protective immune response in experiments conducted on monkeys, according to a study published in the journal Cell.

Please provide your email address to receive an email when new articles are posted on . In vitro findings published in PLOS Pathogens showed that Schistosoma mansoni antigens have the ability to ...

About three years ago, Dr. Leo Stamatatos, an internationally known immunologist then at Seattle BioMed, was ready to abandon his efforts to develop the “holy grail” of HIV vaccine research – a ...

Please provide your email address to receive an email when new articles are posted on . In a small study, researchers detected gastrointestinal pathogens in 45% of men who have sex with men taking HIV ...

Helminth infections are ubiquitous worldwide and can trigger potent immune responses that differ from and potentially antagonize host protective responses to microbial pathogens. In this Review we ...

Aug. 13 (UPI) --A type of antibody can stop the immune system's B cells from fighting pathogens in HIV infections, according to research. Scientists at the National Institute of Allergy and Infectious ...